MedPath

南京星银药业集团有限公司

Ownership
-
Established
2001-09-17
Employees
-
Market Cap
-
Website
www.xyyy2018.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Nifedipine Controlled-release Tablets

Product Name
硝苯地平控释片
Approval Number
国药准字H20234610
Approval Date
Dec 5, 2023
NMPA

Zaleplon Tablets

Product Name
扎来普隆片
Approval Number
国药准字H20070223
Approval Date
Aug 22, 2022
NMPA

Adenosine Cyclophosphate for Injection

Product Name
注射用环磷腺苷
Approval Number
国药准字H20063153
Approval Date
Mar 25, 2021
NMPA

Bivalirudin for Injection

Product Name
注射用比伐芦定
Approval Number
国药准字H20213183
Approval Date
Mar 16, 2021
NMPA

Desmopressin Injection

Product Name
注射用醋酸去氨加压素
Approval Number
国药准字H20213125
Approval Date
Feb 10, 2021
NMPA

Desmopressin Injection

Product Name
注射用醋酸去氨加压素
Approval Number
国药准字H20213126
Approval Date
Feb 10, 2021
NMPA

Pefloxacin Mesylate for Injection

Product Name
注射用甲磺酸培氟沙星
Approval Number
国药准字H20059667
Approval Date
Nov 12, 2020
NMPA

Sodium Phosphates Oral Solution

Product Name
磷酸钠盐口服溶液
Approval Number
国药准字H20103801
Approval Date
Nov 10, 2020
NMPA

Triamcinoione Acetonide Nasal Spray

Product Name
星瑞克
Approval Number
国药准字H20020360
Approval Date
Jul 7, 2020
NMPA

Zinc Gluconate Nasal Spray

Product Name
星瑞灵
Approval Number
国药准字H20020644
Approval Date
Jun 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath